SURVIVAL DIFFERENCES IN EUROPEAN PATIENTS WITH AIDS, 1979-89

被引:93
作者
LUNDGREN, JD
PEDERSEN, C
CLUMECK, N
GATELL, JM
JOHNSON, AM
LEDERGERBER, B
VELLA, S
PHILLIPS, A
NIELSEN, JO
DEWIT, S
SOMMEREIJNS, B
NIELSEN, T
JENSEN, G
SKINHOJ, P
BENTSEN, K
GERSTOFT, J
MELBYE, M
RANKI, A
VALLE, SL
KATLAMA, C
BERLUREAU, P
DIETRICH, M
SCHWANDER, S
GOEBEL, FD
KOSMIDIS, J
STERGIOU, G
GOUZIA, T
PAPADOPOULOS, A
BANHEGYI, D
MULCAHY, F
YUST, I
BENISHAI, Z
BENTWICH, Z
SACKS, T
MAAYAN, S
CHIESI, A
ANCARANI, F
SCALISE, G
BERTAGGIA, A
FRANCAVILLA, E
CALONGHI, G
CARGNEL, A
ARLOTTI, M
CIAMMARUGHI, R
COLOMBA, A
DELALLA, F
FASSIO, P
FERLINI, A
FIACCADORI, F
PASETTI, G
机构
[1] UNIV COPENHAGEN, HVIDOVRE HOSP, DK-2650 HVIDOVRE, DENMARK
[2] FREE UNIV BRUSSELS, HOP ST PIERRE, BRUSSELS, BELGIUM
[3] UCL, UNIV COLL & MIDDLESEX SCH MED, LONDON, ENGLAND
[4] SWISS HIV COHORT STUDY, ZURICH, SWITZERLAND
[5] IST SUPER SANITA, VIROL LAB, I-00161 ROME, ITALY
[6] FREDERIKSBERG UNIV HOSP, COPENHAGEN, DENMARK
[7] RIGSHOSP, DK-2100 COPENHAGEN, DENMARK
[8] UNIV HELSINKI, CENT HOSP, HELSINKI, FINLAND
[9] HOP LA PITIE SALPETRIERE, PARIS, FRANCE
[10] BERNHARD NOCHT INST TROP MED, HAMBURG, GERMANY
[11] MED POLIKLIN, MUNICH, GERMANY
[12] LAIKO ATHENS GEN HOSP, ATHENS, GREECE
[13] IKA HOSP 1, ATHENS, GREECE
[14] POSTGRAD MED UNIV, H-1389 BUDAPEST, HUNGARY
[15] ST JAMES HOSP, DUBLIN 8, IRELAND
[16] ICHILOV HOSP, IL-64239 TEL AVIV, ISRAEL
[17] RAMBAM MED CTR, HAIFA, ISRAEL
[18] KAPLAN HOSP, IL-76100 REHOVOT, ISRAEL
[19] HADASSAH UNIV HOSP, IL-91120 JERUSALEM, ISRAEL
[20] UNIV ANCONA, ANCONA, ITALY
[21] OSPED CIVILE, PADUA, ITALY
[22] ARCISPEDALE SANTA MARIA NUOVA, REGIO EMILIA, ITALY
[23] OSPED L SACCO, MILAN, ITALY
[24] OSPED INFERMI RIMINI, RIMINI, ITALY
[25] OSPED CASA DEL SOLE, PALERMO, ITALY
[26] OSPED CIVILE, VICENZA, ITALY
[27] OO RR BERGAMI, BERGAMO, ITALY
[28] OSPED INFERMI FAENZA, FAENZA, ITALY
[29] OSPED RIUNITI PARMA, PARMA, ITALY
[30] OSPED NIGUARDA CA GRANDA, MILAN, ITALY
[31] OSPED AMEDEO SAVOIA, TURIN, ITALY
[32] OSPED L SACCO, MILAN, ITALY
[33] OSPED SANTA ANDREA, LA SPEZIA, ITALY
[34] UNIV CATANIA, CATANIA, ITALY
[35] UNIV CATTOLICA SACRO CUORE, ROME, ITALY
[36] UNIV SASSARI, I-07100 SASSARI, ITALY
[37] POLICLIN MONTELUCE, PERUGIA, ITALY
[38] OSPED GALLIERA, GENOA, ITALY
[39] OSPED SANTA MARIA CROCI, RAVENNA, ITALY
[40] OSPED MAGGIORE NOVARA, NOVARA, ITALY
[41] OSPED SANTA MARIA MADDALENA, TRIESTE, ITALY
[42] CTR HOSP, LUXEMBOURG, LUXEMBOURG
[43] UNIV AMSTERDAM, ACAD ZIEKENHUIS, AMSTERDAM, NETHERLANDS
[44] HOSP SANTA MARIA, LISBON, PORTUGAL
[45] HOSP CURRY CABRAL, LISBON, PORTUGAL
[46] INST SALUD CARLOS 3, MADRID, SPAIN
[47] HOSP CLIN BARCELONA, BARCELONA, SPAIN
[48] HOSP GERMANS TRIAS & PUJOL, BARCELONA, SPAIN
[49] KAROLINSKA INST, STOCKHOLM, SWEDEN
[50] CHU VAUDOIS, CH-1011 LAUSANNE, SWITZERLAND
来源
BMJ-BRITISH MEDICAL JOURNAL | 1994年 / 308卷 / 6936期
关键词
D O I
10.1136/bmj.308.6936.1068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives-To examine the pattern of survival and factors associated with the outcome of disease in patients with AIDS. Design-Inception cohort. Data collected retrospectively from patients' charts. Setting-52 clinical centres in 17 European countries. Subjects-6578 adults diagnosed with AIDS from 1 January 1979 to 31 December 1989. Main outcome measures-Survival after the time of diagnosis. Results-The median survival after diagnosis was 17 months, with an estimated survival at three years of 16% (95% confidence interval 15% to 17%). Patients diagnosed in southern Europe had a shorter survival, particularly immediately after the time of diagnosis, compared with patients diagnosed in central and northern Europe (survival at one year (95% confidence interval) 54% (52% to 56%) 66% (64% to 68%), 65% (63% to 66%), respectively. The three year survival, however, was similar for all regions. The regional differences in survival were less pronounced for patients diagnosed in 1989 compared with earlier years. Improved survival in recent years was observed for patients with a variety of manifestations used to define AIDS but was significant only for patients diagnosed with Pneumocystis carinii pneumonia. The three S ear survival, however, remains unchanged over time. Conclusions-Survival of AIDS patients seems to vary within Europe, being shorter in southern than central and northern Europe. The magnitude of these differences, however, has declined gradually over time. Short term survival has improved in recent years, but the long term prognosis has remained equally poor, reflecting the fact that the underlying infection with HIV and many of the complicating diseases remains essentially uncontrolled.
引用
收藏
页码:1068 / 1073
页数:6
相关论文
共 19 条
[1]   PRELIMINARY-ANALYSIS OF THE CONCORDE TRIAL [J].
ABOULKER, JP ;
SWART, AM .
LANCET, 1993, 341 (8849) :889-890
[2]   PROGNOSTIC FACTORS AND LIFE EXPECTANCY OF PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND PNEUMOCYSTIS-CARINII PNEUMONIA [J].
BRENNER, M ;
OGNIBENE, FP ;
LACK, EE ;
SIMMONS, JT ;
SUFFREDINI, AF ;
LANE, HC ;
FAUCI, AS ;
PARRILLO, JE ;
SHELHAMER, JH ;
MASUR, H .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (05) :1199-1206
[3]  
BUIRA E, 1992, J ACQ IMMUN DEF SYND, V5, P737
[4]   THE SAFETY AND EFFICACY OF ZIDOVUDINE (AZT) IN THE TREATMENT OF SUBJECTS WITH MILDLY SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) INFECTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISCHL, MA ;
RICHMAN, DD ;
HANSEN, N ;
COLLIER, AC ;
CAREY, JT ;
PARA, MF ;
HARDY, WD ;
DOLIN, R ;
POWDERLY, WG ;
ALLAN, JD ;
WONG, B ;
MERIGAN, TC ;
MCAULIFFE, VJ ;
HYSLOP, NE ;
RHAME, FS ;
BALFOUR, HH ;
SPECTOR, SA ;
VOLBERDING, P ;
PETTINELLI, C ;
ANDERSON, J .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (10) :727-737
[5]   THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISCHL, MA ;
RICHMAN, DD ;
GRIECO, MH ;
GOTTLIEB, MS ;
VOLBERDING, PA ;
LASKIN, OL ;
LEEDOM, JM ;
GROOPMAN, JE ;
MILDVAN, D ;
SCHOOLEY, RT ;
JACKSON, GG ;
DURACK, DT ;
KING, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) :185-191
[6]  
FRIEDLAND GH, 1991, J ACQ IMMUN DEF SYND, V4, P144
[7]   A CONTROLLED TRIAL OF EARLY VERSUS LATE TREATMENT WITH ZIDOVUDINE IN SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - RESULTS OF THE VETERANS AFFAIRS COOPERATIVE STUDY [J].
HAMILTON, JD ;
HARTIGAN, PM ;
SIMBERKOFF, MS ;
DAY, PL ;
DIAMOND, GR ;
DICKINSON, GM ;
DRUSANO, GL ;
EGORIN, MJ ;
GEORGE, WL ;
GORDIN, FM ;
HAWKES, CA ;
JENSEN, PC ;
KLIMAS, NG ;
LABRIOLA, AM ;
LAHART, CJ ;
OBRIEN, WA ;
OSTER, CN ;
WEINHOLD, KJ ;
WRAY, NP ;
ZOLLAPAZNER, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (07) :437-443
[8]  
HARRIS J E, 1990, Journal of the American Medical Association, V263, P397, DOI 10.1001/jama.263.3.397
[9]   SURVIVAL FOR WOMEN AND MEN WITH AIDS [J].
LEMP, GF ;
HIROZAWA, AM ;
COHEN, JB ;
DERISH, PA ;
MCKINNEY, KC ;
HERNANDEZ, SR .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (01) :74-79
[10]   SURVIVAL TRENDS FOR PATIENTS WITH AIDS [J].
LEMP, GF ;
PAYNE, SF ;
NEAL, D ;
TEMELSO, T ;
RUTHERFORD, GW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (03) :402-406